RE: Astrazenica may use HUMAN challenge studies as COVID 19 is becoming low in the population at large!29 May 2020 10:03
I dont want to get accused of crazy prices and ramping like what was mentioned on here yesterday so my valuation of imutex was based on a take over of £500,000,000. Its 4.9p per share at £100,000,000 at 49%